As of 2026-01-03, the EV/EBITDA ratio of NantHealth Inc (NH) is -8.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NH's latest enterprise value is 336.09 mil USD. NH's TTM EBITDA according to its financial statements is -37.78 mil USD. Dividing these 2 quantities gives us the above NH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.4x - 13.0x | 8.3x |
| Forward P/E multiples | 8.1x - 20.6x | 14.4x |
| Fair Price | (81.81) - (106.23) | (98.06) |
| Upside | -6159.6% - -7968.7% | -7363.8% |
| Date | EV/EBITDA |